DZ BANK upgraded Sartorius (ETR:SRT) to Buy in a statement released earlier today.
- Updated: September 16, 2016
DZ BANK has upgraded Sartorius(ETR:SRT) to Buy in a statement released on 9/17/2016.
Having a price of 74.44EUR, Sartorius (ETR:SRT) traded 2.17% higher on the day. The last stock price close is up 26.24% relative to the two hundred day moving average, compared with the S&P 500 which has fallen -0.01% over the date range. SRT has recorded a 50-day average of 4.94EUR and 200-day moving average of 4.48EUR. Trading volume was was down over the average, with 10,732 shares of SRT changing hands under the typical 11,765 shares.
Recent Performance Graph:
With a market capitalization of 0.0 EUR, Sartorius has a one-year low of 3.25EUR and a 52 week high of 5.83EUR with a price-earnings ratio of 0.
A total of 2 firms have released a report on the stock. Zero rate the stock a strong buy, 0 rate the stock a buy, two firms rate the company a hold, 0 rate the stock to underperform, and finally 0 brokeragesrate the stock as sell with a 12-month target price of 5.50EUR
General Information About Sartorius (ETR:SRT)
Sartorius AG is a Germany-based holding company engaged in the provision of laboratory and process technologies, as well as equipment. The Company operates three business segments: Bioprocess Solutions; Lab Products & Services, and Industrial Weighing. The Bioprocess Solutions segment provides integrated solutions for the pharmaceutical industry, including filtration systems, process control tools, purification equipment and fluid management, among others. The Lab Products & Services segment is a supplier of laboratory instruments, consumables and services for the pharmaceutical research and quality assurance laboratories, chemical and food industries as well as for the academic sector. The Industrial Weighing segment provides a range of measurement and inspection systems primarily for the food processing, chemical, pharmaceutical and basic materials sectors. The Company’s activities are carried out via subsidiaries primarily in Europe, and North America and Asia/Pacific regions.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.